Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.84
Funders
Pfizer
AstraZeneca
GlaxoSmithKline
COPD Foundation
Sunovion
Australian Government
National Institutes of Health
Genentech
National Health and Medical Research Council
National Heart, Lung, and Blood Institute
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Polygenic and transcriptional risk scores identify chronic obstructive pulmonary disease subtypes in the COPDGene and ECLIPSE cohort studies
Gary P. Anderson, Gregory L. Kinney, Brian D. Hobbs, J.W. Chiles et al.
Citations
2 citations
Journal
EBioMedicine
Topics
Chronic Obstructive Pulmonary Disease (COPD) Research
Field-Weighted Citation Impact (FWCI)
0.84
article
Polygenic and transcriptional risk scores identify chronic obstructive pulmonary disease subtypes in the COPDGene and ECLIPSE cohort studies
Gary P. Anderson, Gregory L. Kinney, Brian D. Hobbs, J.W. Chiles, Russell Paul Bowler, Katherine Pratte, Auyon Ghosh, Merry‐Lynn McDonald, Edwin K. Silverman, Rui‐Sheng Wang, Ruth Tal‐Singer, Davin Hill, Jennifer Dy, Don D. Sin, John Platig, Jeffrey L. Curtis, Craig P. Hersh, Iain R. Konigsberg, Kimberly Glass, Julian Hecker, Majd Mouded, Stephen I. Rennard, Matthew Moll, Michael Cho, Jingzhou Zhang, Peter J. Castaldi
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
EBioMedicineVol. 110
Institutions
Boston University (US), University of Nebraska at Omaha (US), Brigham and Women's Hospital (US), Boston Medical Center (US), Northeastern University (US), University of British Columbia (CA), Colorado School of Public Health (US), The University of Melbourne (AU), Regeneron (United States) (US), SUNY Upstate Medical University (US), University Medical Center (US), National Jewish Health (US), University of Alabama at Birmingham (US), VA Ann Arbor Healthcare System (US), Novartis (United States) (US), St. Paul's Hospital (CA), University of Virginia (US), University of Colorado Anschutz Medical Campus (US), University of Nebraska Medical Center (US), University of Colorado Denver (US)
Funders
Pfizer, AstraZeneca, GlaxoSmithKline, COPD Foundation, Sunovion, Australian Government, National Institutes of Health, Genentech, National Health and Medical Research Council, National Heart, Lung, and Blood Institute
Sustainable Development Goals
Good health and well-being
OpenAlex Percentile
Openalex Percentile: Top 23%
Topics
Chronic Obstructive Pulmonary Disease (COPD) Research